Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)

查看全文 作　　者：Xinguang [1]Wang;Zhaoqing [1]Fan

机构地区：[1]Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Breast Center,Peking University Cancer Hospital&Institute,Beijing 100142,China

出　　处：《Chinese Journal of Cancer Research》索引2022年第34卷第5期,共2页

摘　　要：China is facing growing number of cancer cases and deaths,as well as growing crude incidence and mortality of cancer.Breast cancer is the most common cancer type in females in China and the incidence rate for breast cancer in Chinese females has increased during the last two decades.However, breast cancer prognosis in China is poorer than that in developed countries. Population aging may at least partially explain the transition of cancer profiles we have seen in recent years. Breast cancer screening technologies and public healthcare strategies targeting the high-risk population are being developed to reduce the cancer burden in China. 关键词：BREAST DIAGNOSIS BREAST

相关文献

参考文献（1）
引证文献（4）
耦合文献（3）

参考文献(1)

引证文献(4)

耦合文献(3)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)

参考文献(1)

引证文献(4)

耦合文献(3)

用户提示